Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Orion Market Research | PRODUCT CODE: 1078124

Cover Image

PUBLISHER: Orion Market Research | PRODUCT CODE: 1078124

Global Cardiac Biomarker Market 2022-2028

PUBLISHED:
PAGES: 125 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4000
Printable PDF & Excel (Corporate License)
USD 6625

Add to Cart

Cardiac Biomarker Market by Type (Creatine Kinase, Troponins, Myoglobin, Ischemia Modified Albumin, and Others), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), by Location of Testing (Laboratory Testing and Point of Care Testing) - Global Industry Share, Growth, Competitive Analysis and Forecast Period 2022-2028

The globalcardiac biomarker market is anticipated to grow at a CAGR of 7.8%during the forecast period. Cardiac biomarkers are substances that are discharged into the blood when the heart is harmed or focused. Estimations of these biomarkers are utilized to analyze acute coronary syndrome (ACS) and cardiac ischemia, and conditions related to lack of bloodstream to the heart. Tests for cardiac biomarkers help measure an individual's risk condition or screen and oversee an individual suspected ofACS and cardiac ischemia.

Several drivers are driving the cardiac biomarker market globally such as a rise in cardiovascular diseases, a rise in the geriatric population, and technological development. The rise in the geriatric population and the rise in cardiac vascular diseases are the major factors that affect the growth of the market as the biomarkers are utilized for detection of the cardiac problems. According to the CDC,one person dies every 36 seconds in the US from cardiovascular disease. About 659,000 people in the US die from heart disease each year-that's 1 in every 4 deaths. Heart disease costs the US about $363 billion each year from 2016 to 2017.

Cardiac biomarkers providean instant and accurate prediction of heart failure after chest pain, and these factors fuel the growth of the market. The market is also affected by the technological development of cardiac biomarkers. Consumption of tobacco or change in lifestyleis other factors that lead to an increase in cardiovascular diseases. According to the American heart association, that heart disease remains the prior cause of mortality in the US.

The cardiac biomarker has been segmented based on type,application, and location of testing. By type, the market issegmented into Creatine Kinase(CK-MB), troponins (T,I), myoglobin, natriuretic peptides( BNP& NT-proBNP), ischemia-modified albumin, and others. Based on application, the market issegmented into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis, and others. Based onthe location of testing, the market is segmented intopoint of care(POC) testing and laboratory testing.

Geographically, the worldwide cardiac biomarkershowcase is divided into North America, Europe, Asia-Pacific, and the Rest of the World.The Asia-Pacificmarket is considered to be the fastest-growing market globally.The rise in the number of cardiovascular patients in the Asia-Pacific region is considered to rise eventually enabling the cardiac biomarker market to grow. North America and Europe are considered to be the dominating markets due to various factors such as high healthcare expenditure, development in the technology, support from the government, and rise in the key players.

Some of the key players in the cardiac biomarker market include Abbott Laboratories Inc., Becton, Dickson & Co., Bio-Rad Laboratories, Randox Laboratories Ltd., Siemens AG, and Thermo Fisher Scientific Inc., among others.

Research Methodology

The market study of the global cardiac biomarker market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Whitepapers, researchpapers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of the market size andintended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • Global Cardiac Biomarker Market Research and Analysis by Type
  • Global Cardiac Biomarker Market Research and Analysis by Application
  • Global Cardiac Biomarker Market Research and Analysis by Location of Testing

OMR Report Covers:

  • Comprehensive research methodology of global cardiac biomarker market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global cardiac biomarker market.
  • Insights about market determinants that are stimulating the global cardiac biomarker market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Product Code: OMR2017204

Table of Contents

Category- Biotechnology

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Cardiac Biomarker Market
  • Recovery Scenario of Global Cardiac Biomarker Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown

.2.1. By Segments

    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Cardiac Biomarker Market by Type
    • 5.1.1. Creatine Kinase(CK-MB)
    • 5.1.2. Troponins(T,I)
    • 5.1.3. Myoglobin
    • 5.1.4. Ischemia Modified Albumin
    • 5.1.5. Others
  • 5.2. Global Cardiac Biomarker Market by Application
    • 5.2.1. Myocardial Infarction
    • 5.2.2. Congestive Heart Failure
    • 5.2.3. Acute Coronary Syndrome
    • 5.2.4. Atherosclerosis
    • 5.2.5. Others
  • 5.3. Global Cardiac Biomarker Market by Location of Testing
    • 5.3.1. Laboratory Testing
    • 5.3.2. Point of Care Testing

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories Inc.
  • 7.2. Atlas Medical
  • 7.3. Becton, Dickson & Co.
  • 7.4. BG Medicine Inc.
  • 7.5. BioMerieux S.A.
  • 7.6. Bio-Rad Laboratories Inc.
  • 7.7. Cisbio Bioassays SAS
  • 7.8. Creative Diagnostics
  • 7.9. Critical Diagnostics
  • 7.10. F. Hoffmann La Roche Ltd.
  • 7.11. HyTest Ltd
  • 7.12. LifeSign LLC
  • 7.13. Luminex Corp.
  • 7.14. Meso Scale Diagnostics LLC
  • 7.15. Myriad RBM
  • 7.16. Randox Laboratories Ltd.
  • 7.17. Response Biomedical Corp.
  • 7.18. Siemens AG
  • 7.19. Signosis Inc.
  • 7.20. Thermo Fisher Scientific Inc.
Product Code: OMR2017204

LIST OF TABLES

  • 1. GLOBAL CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS, 2021-2028 ($ MILLION)
  • 2. GLOBAL CARDIAC BIOMARKER MARKET BY TYPE, 2021-2028 ($ MILLION)
  • 3. GLOBAL CREATINE KINASEMARKET BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL TROPONINSMARKET BY REGION, 2021-2028 ($ MILLION)
  • 5. GLOBAL MYOGLOBIN MARKET BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL ISCHEMIA MODIFIED ALBUMIN MARKET BY REGION, 2021-2028 ($ MILLION)
  • 7. GLOBAL OTHER CARDIAC BIOMARKER MARKET BY REGION, 2021-2028 ($ MILLION)
  • 8. GLOBAL CARDIAC BIOMARKER MARKET BY APPLICATION, 2021-2028 ($ MILLION)
  • 9. GLOBAL MYOCARDIAL INFRACTION BIOMARKER MARKET BY REGION, 2021-2028 ($ MILLION)
  • 10. GLOBAL CONGESTIVE HEART FAILURE BIOMARKER MARKET BY REGION, 2021-2028 ($ MILLION)
  • 11. GLOBAL ACUTE CORONARY SYNDROME BIOMARKER MARKET BY REGION, 2021-2028 ($ MILLION)
  • 12. GLOBAL ATHEROSCLEROSIS BIOMARKER MARKET BY REGION, 2021-2028 ($ MILLION)
  • 13. GLOBAL OTHER CARDIAC BIOMARKER MARKET BY REGION, 2021-2028 ($ MILLION)
  • 14. GLOBAL CARDIAC BIOMARKER MARKET BY LOCATION OF TESTING, 2021-2028 ($ MILLION)
  • 15. GLOBAL CARDIAC BIOMARKER IN LABORATORY TESTING MARKET BY REGION, 2021-2028 ($ MILLION)
  • 16. GLOBAL CARDIAC BIOMARKER IN POINT OF CARE TESTING MARKET BY REGION, 2021-2028 ($ MILLION)
  • 17. GLOBAL CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
  • 18. NORTH AMERICAN CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 19. NORTH AMERICAN CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 20. NORTH AMERICAN CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2021-2028 ($ MILLION)
  • 21. NORTH AMERICAN CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 22. EUROPEAN CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 23. EUROPEAN CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 24. EUROPEAN CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2021-2028 ($ MILLION)
  • 25. EUROPEAN CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 26. ASIA-PACIFIC CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 27. ASIA-PACIFIC CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 28. ASIA-PACIFIC CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2021-2028 ($ MILLION)
  • 29. ASIA-PACIFIC CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 30. REST OF THE WORLD CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 31. REST OF THE WORLD CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 32. REST OF THE WORLD CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL CARDIAC BIOMARKER MARKET SHARE BY TYPE, 2021 VS 2028 (%)
  • 2. GLOBAL CARDIAC BIOMARKER MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
  • 3. GLOBAL CARDIAC BIOMARKER MARKET SHARE BY LOCATION OF TESTING, 2021 VS 2028 (%)
  • 4. GLOBAL CARDIAC BIOMARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028, (%)
  • 5. GLOBAL CREATINE KINASE (CK-MB) MARKET BY REGION, 2021 VS 2028 (%)
  • 6. GLOBAL TROPONINS (T, I) MARKET BY REGION, 2021 VS 2028 (%)
  • 7. GLOBAL MYOGLOBIN MARKET BY REGION, 2021 VS 2028 (%)
  • 8. GLOBAL ISCHEMIA MODIFIED ALBUMIN MARKET BY REGION, 2021 VS 2028 (%)
  • 9. GLOBAL OTHER CARDIAC BIOMARKER MARKET BY REGION, 2021 VS 2028 (%)
  • 10. GLOBAL MYOCARDIAL INFRACTION BIOMARKER MARKET BY REGION, 2021 VS 2028 (%)
  • 11. GLOBAL CONGESTIVE HEART FAILURE BIOMARKER MARKET BY REGION, 2021 VS 2028 (%)
  • 12. GLOBAL ACUTE CORONARY SYNDROME BIOMARKER MARKET BY REGION, 2021 VS 2028 (%)
  • 13. GLOBAL ATHEROSCLEROSIS BIOMARKER MARKET BY REGION, 2021 VS 2028 (%)
  • 14. GLOBAL OTHER CARDIAC BIOMARKER MARKET BY REGION, 2021 VS 2028 (%)
  • 15. GLOBAL CARDIAC BIOMARKER IN LABORATORY TESTING MARKET BY REGION, 2021 VS 2028 (%)
  • 16. GLOBAL CARDIAC BIOMARKER IN POINT OF CARE TESTING MARKET BY REGION, 2021 VS 2028 (%)
  • 17. US CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 18. CANADA MARKET CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 19. UK CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 20. GERMANY CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. SPAIN CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. FRANCE CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. ITALY CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 24. REST OF EUROPE CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 25. INDIA CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 26. CHINA CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 27. JAPAN CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 28. REST OF ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 29. REST OF WORLD CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!